InvestorsHub Logo
Followers 26
Posts 165
Boards Moderated 0
Alias Born 12/16/2015

Re: sentiment_stocks post# 47991

Monday, 12/21/2015 2:52:59 PM

Monday, December 21, 2015 2:52:59 PM

Post# of 745650
If you want to get picky, enrollment into the ph3 study has been sloooooow and delayed, even before they added patients and stopped screening for new patients.

That just shows you how little demand there is for DCVax. No one cares about it.

Ten years to enroll 348 patients. Pathetic.

Celldex enrolled almost 750 GBM patients into the ACT-IV study in three years.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News